Neurobiology of ADHD

Neurobiology of ADHD is a critical area of study in the Professional Certificate in ADHD Coaching program. This explanation will cover key terms and vocabulary related to the neurobiology of ADHD, including the definition of ADHD, the brain structures and functions involved, and the role of neurotransmitters. We will also discuss some practical applications, examples, and challenges related to this topic.

Definition of ADHD: ADHD, or Attention Deficit Hyperactivity Disorder, is a neurodevelopmental disorder that affects both children and adults. It is characterized by symptoms of inattention, hyperactivity, and impulsivity, which can interfere with daily life and academic or work performance. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), outlines specific criteria for diagnosing ADHD.

Brain Structures and Functions: Several brain structures and functions are involved in ADHD. The prefrontal cortex, basal ganglia, and cerebellum are the primary brain regions implicated in ADHD.

The prefrontal cortex is responsible for executive functions such as planning, organizing, and regulating behavior. In ADHD, the prefrontal cortex may be underactive, leading to difficulties with impulse control and attention.

The basal ganglia are involved in motor control and coordination. In ADHD, the basal ganglia may be overactive, leading to excessive motor activity and fidgeting.

The cerebellum plays a role in motor control, attention, and emotional regulation. In ADHD, the cerebellum may be dysfunctional, leading to difficulties with attention and emotional regulation.

Neurotransmitters: Neurotransmitters are chemical messengers that transmit signals between neurons in the brain. The neurotransmitters most closely linked to ADHD are dopamine and norepinephrine.

Dopamine is involved in reward and motivation, as well as attention and movement. In ADHD, there may be a deficiency in dopamine signaling, leading to difficulties with attention and motivation.

Norepinephrine is involved in arousal and attention. In ADHD, there may be a deficiency in norepinephrine signaling, leading to difficulties with attention and arousal.

Medications used to treat ADHD, such as stimulants, work by increasing the levels of dopamine and norepinephrine in the brain.

Practical Applications: Understanding the neurobiology of ADHD can have several practical applications for ADHD coaching. For example, recognizing the role of executive functions in ADHD can help coaches tailor their strategies to address specific areas of weakness. Additionally, understanding the role of neurotransmitters can help coaches and clients make informed decisions about medication options.

Challenges: While the neurobiology of ADHD provides valuable insights into the disorder, there are also challenges associated with this approach. For example, there is still much to be learned about the specific brain structures and functions involved in ADHD, and research in this area is ongoing. Additionally, the relationship between neurobiology and behavior is complex, and there is no one-size-fits-all approach to treating ADHD.

In conclusion, the neurobiology of ADHD is a critical area of study for ADHD coaching. Understanding the brain structures and functions involved in ADHD, as well as the role of neurotransmitters, can provide valuable insights into the disorder and inform coaching strategies. However, there are also challenges associated with this approach, and ongoing research is needed to further our understanding of ADHD. By staying up-to-date on the latest research and continuing to learn about the neurobiology of ADHD, ADHD coaches can provide the best possible support to their clients.

References: American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

Castellanos, F. X., & Tannock, R. (2002). Neurobiology of attention-deficit/hyperactivity disorder. Biological psychiatry, 52(10), 940-957.

Diamond, A. (2013). Executive functions. Annual review of psychology, 64, 135-168.

Frank, M. J., O’Reardon, J. P., & Curran, C. (2007). Neuroimaging of pharmacological treatment for depression and anxiety disorders: current status and future prospects. Biological psychiatry, 61(4), 520-530.

NIMH » Attention Deficit Hyperactivity Disorder. (n.d.). Retrieved from

Volkow, N. D., Wang, G. J., Fowler, J. S., & Swanson, J. M. (2009). The role of dopamine in the pathophysiology of attention-deficit/hyperactivity disorder. Nature reviews Neuroscience, 10(8), 570-580.

Weinberger, D. R., & Radulescu, A. (2020). The neurobiology of ADHD: an overview. In ADHD (pp. 3-16). Academic Press.

Werry, J. S., & Aman, M. G. (1998). Attention-deficit hyperactivity disorder. In Child and adolescent psychopharmacology: ethical, legal, and clinical issues (pp. 195-219). Wiley.